The U.S. Meals and Drug Administration mentioned it has seized “hundreds of models” of counterfeit Ozempic, the diabetes drug broadly used for weight reduction, that had been distributed by legit drug provide sources.

The FDA and the drug’s maker, Novo Nordisk, are testing the photographs. They don’t but have details about the medicine’ identification, high quality or security, in response to a press release. 5 diseases have been linked to the pretend photographs, however none have been severe, the FDA mentioned Thursday.

A number of the pretend 1 milligram semaglutide photographs should still be on the market, FDA mentioned. Along with the drug itself, the needles, pen labels, carton and accompanying well being care data are additionally counterfeit, the company mentioned.

It mentioned the counterfeits had been labeled with the lot quantity NAR0074 and serial quantity 430834149057.

FDA suggested retail pharmacies to purchase genuine Ozempic solely by approved distributors and for sufferers to get it solely by state-licensed pharmacies.